Simó Schwartz

FAQ About Simó Schwartz

• What is Simó Schwartz's address?

  Simó Schwartz is located at
  Greater Barcelona Metropolitan Area, Greater Barcelona Metropolitan Area, Spain

• What is Simó Schwartz's job title?

  Simó Schwartz is a
  Strategy director for biobanking and biomodels at the Vall d'Hebron Hospital Barcelona Campus and Head of Research and Innovation of the Clinical Biochemistry Department of the Vall d'Hebron Hospital. Former director general of Banc de Sang i Teixits (Blood and Tissue Bank, BST), Catalonia. The BST is a public agency of the Catalan Department of Health whose mission is to guarantee the supply and proper use of human blood and tissue in Catalonia. It is also the leading center in the field of immuno-diagnostics and advanced therapy development. Former director of CIBBIM-Nanomedicine (www.cibbim.eu), a research center focused on advanced therapies and nanomedicine. Former member of the Internal Scientific Committee of the Vall d’Hebron Research Institute (VHIR; www.vhir.org) acting as appointed Director Assistant in Translational Research (2017-2021). Clinical coordinator of the CIBBIM-pre-analytical laboratory Service for rare diseases of the Vall d'Hebron Hospital Campus (www.vallhebron.com). He was appointed as member of the Advisory Board of NANOCAN, Southern Denmark University, and deputy director of CIBER-BBN, a center from the Spanish Health Institute Carlos III (ISCIII) which gathers research groups of international excellence in nanotechnology and nanomedicine. Co-founder of BSure Medical SL, a Spin-Off company from VHIR that commercialises tests to prevent severe immune adverse reactions to implanted biomaterials. He was also Co-founder and Science Advisor of ARGON Pharma SL, and former member of the editorial Board of the journals Nanomedicine-NBM and Eur. J. Nanomedicine. External science advisor of the European Nanomedicine Characterization Laboratory (EU-NCL) and eventual science consultant. Dr Schwartz Jr helds 18 patents, most transferred to leading companies of the biotech and pharma sectors and coauthors more than 120 papers in high impact factor journals. Recently appointed as associate editor of Precision Nanomedicine journal, he also acts as coordinator and partner of several research projects directly related with the obtention and validation of therapeutic drug delivery systems in the fields of cancer, infectious diseases, regenerative medicine, and rare diseases (international projects including several EU funded projects) involving SME’s and large Pharma companies. Acting as coordinator for technology transfer at CIBER-BBN, he was recently appointed as President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. European Medicines Agency

• What industry does Simó Schwartz currently work in?

  Simó Schwartz currently works in the
  European Medicines Agency

• What is Simó Schwartz's area of expertise?

  Simó Schwartz specializes in
  Strategy director for biobanking and biomodels at the Vall d'Hebron Hospital Barcelona Campus and Head of Research and Innovation of the Clinical Biochemistry Department of the Vall d'Hebron Hospital. Former director general of Banc de Sang i Teixits (Blood and Tissue Bank, BST), Catalonia. The BST is a public agency of the Catalan Department of Health whose mission is to guarantee the supply and proper use of human blood and tissue in Catalonia. It is also the leading center in the field of immuno-diagnostics and advanced therapy development. Former director of CIBBIM-Nanomedicine (www.cibbim.eu), a research center focused on advanced therapies and nanomedicine. Former member of the Internal Scientific Committee of the Vall d’Hebron Research Institute (VHIR; www.vhir.org) acting as appointed Director Assistant in Translational Research (2017-2021). Clinical coordinator of the CIBBIM-pre-analytical laboratory Service for rare diseases of the Vall d'Hebron Hospital Campus (www.vallhebron.com). He was appointed as member of the Advisory Board of NANOCAN, Southern Denmark University, and deputy director of CIBER-BBN, a center from the Spanish Health Institute Carlos III (ISCIII) which gathers research groups of international excellence in nanotechnology and nanomedicine. Co-founder of BSure Medical SL, a Spin-Off company from VHIR that commercialises tests to prevent severe immune adverse reactions to implanted biomaterials. He was also Co-founder and Science Advisor of ARGON Pharma SL, and former member of the editorial Board of the journals Nanomedicine-NBM and Eur. J. Nanomedicine. External science advisor of the European Nanomedicine Characterization Laboratory (EU-NCL) and eventual science consultant. Dr Schwartz Jr helds 18 patents, most transferred to leading companies of the biotech and pharma sectors and coauthors more than 120 papers in high impact factor journals. Recently appointed as associate editor of Precision Nanomedicine journal, he also acts as coordinator and partner of several research projects directly related with the obtention and validation of therapeutic drug delivery systems in the fields of cancer, infectious diseases, regenerative medicine, and rare diseases (international projects including several EU funded projects) involving SME’s and large Pharma companies. Acting as coordinator for technology transfer at CIBER-BBN, he was recently appointed as President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine.

• Which languages does Simó Schwartz speak? 

  Simó Schwartz speaks the following languages:
  No languages available.

• Which industries has Simó Schwartz previously worked in?   

  Simó Schwartz has prior experience in the following industries:
  Banc De Sang I Teixits , Vall Dhebron Institute Of Research Vall Dhebron Institut De Recerca , European Nanomedicine Characterization Laboratory Eu Ncl , European Journal Nanomedicine , Som Biotech , Celgene , Swedish Research Council , Nanomedicine Nbm , Vall Dhebron Barcelona Hospital Campus , Biomedical Research Networking Center In Bioengineering Biomaterials And Nanomedicine , Biomedical Research Networking Center In Bioengineering Biomaterials And Nanomedicine , Preclinical Studies Platform At Cibbim Nanomedicine , Cibbim Nanomedicine Vhir Vall Dhebron Institut De Recerca , Oryzon Genomics , Cibbim Nanomedicine Vhir Vall Dhebron Institut De Recerca

• What is Simó Schwartz’s work experience?  

  Simó Schwartz has the following professional experience:
  European Medicines Agency , Atheneum Partners , Banc De Sang I Teixits , Bsure Medical , Journal Of Nanotheranostics , Precision Nanomedicine Journal , Vall Dhebron Institute Of Research Vall Dhebron Institut De Recerca , European Society Of Nanomedicine , International Society For Nanomedicine , European Nanomedicine Characterization Laboratory Eu Ncl , European Journal Nanomedicine , Som Biotech , Celgene , Swedish Research Council , Nanomedicine Nbm , Vall Dhebron Barcelona Hospital Campus , Biomedical Research Networking Center In Bioengineering Biomaterials And Nanomedicine , Biomedical Research Networking Center In Bioengineering Biomaterials And Nanomedicine , Preclinical Studies Platform At Cibbim Nanomedicine , Cibbim Nanomedicine Vhir Vall Dhebron Institut De Recerca , Oryzon Genomics , Cibbim Nanomedicine Vhir Vall Dhebron Institut De Recerca .

• How can I find Simó Schwartz on LinkedIn?  

  You can view Simó Schwartz’s
  LinkedIn profile at LinkedIn URL.

• What are Simó Schwartz’s work email addresses?  

  Simó Schwartz’s work email addresses are
  [email protected] .

• What company does Simó Schwartz work for?  

  Simó Schwartz works at
  European Medicines Agency